Latest / Stock Movers / BP Gains, Sanofi Rises, Puma Pounces
Transcript
- 0:02Speaker 1: Bloomberg Audio Studios.
- 0:04Speaker 2: Podcasts.
- 0:05Speaker 1: Radio.
- 0:06Speaker 2: News.
- 0:08Speaker 1: The Stock Movers Report. Your roundup of companies making moves
- 0:12Speaker 1: in the stock market. Harnessing the power of Bloomberg data. Stephen,
- 0:16Speaker 1: thank you so much.
- 0:17Speaker 3: Let's have a look at some of the stocks on
- 0:19Speaker 3: the move today in Europe. I'm Caroline Hepke with Stephen Carroll.
- 0:22Speaker 3: We're joined by Bloomberg reporter Josh Gorn-Warner. Good to see
- 0:25Speaker 3: you this Friday. Let's start with BP reporting its highest
- 0:29Speaker 3: profits in 18 years.
- 0:30Speaker 1: Yes. Yes.
- 0:32Speaker 2: So, adjusted profit surged to almost $ 8. 5 billion in the quarter.
- 0:36Speaker 2: That was almost four times the figure that was reported
- 0:39Speaker 2: just a year earlier. And the main driver there has
- 0:42Speaker 2: been bumper refining margins that boosted those earnings well above expectations.
- 0:47Speaker 2: The other part of the story today is the ongoing
- 0:50Speaker 2: reduction in debt. We saw that figure tumble to just
- 0:53Speaker 2: under $ 14 billion from over $ 22 billion just three months ago. So,
- 0:58Speaker 2: that means that BP has actually hit its target about
- 1:00Speaker 2: a year ahead of schedule. And that's important because it
- 1:03Speaker 2: means that BP is moving closer to where it might
- 1:05Speaker 2: be able to restart share buybacks, which is obviously something
- 1:08Speaker 2: that investors are very keen on. However, the firm did
- 1:11Speaker 2: say the immediate focus is paying off the remaining liabilities
- 1:14Speaker 2: from the Deepwater Horizon disaster back in 2010. We've got
- 1:19Speaker 2: CEO Meg O'Neill, who took over in April. She is
- 1:22Speaker 2: due to outline her longer-term strategy for the company in December.
- 1:26Speaker 2: But for today, shares are up about 1%, moving closer
- 1:30Speaker 2: to the 2010 high that was hit last week. And
- 1:32Speaker 2: most oil peers are following prices higher on signs that
- 1:35Speaker 2: the U.S. may resume military strikes against Iran.
- 1:39Speaker 3: Okay.
- 1:39Speaker 1: So, that's on BP.
- 1:40Speaker 2: Let's turn next to the French drugmaker Sanofi raising its outlook.
- 1:44Speaker 1: Yes.
- 1:44Speaker 2: So, forecasts for both sales and profit have been raised
- 1:48Speaker 2: for this year. And that follows an upgrade in the
- 1:51Speaker 2: previous quarter. And this is being driven by rising demand
- 1:54Speaker 2: for its top-selling skin and asthma drug called Dupiquent. Shares
- 2:01Speaker 2: are up over 5% today and trading at a six-month high. So,
- 2:05Speaker 2: the strength in that drug is managing to outweigh softer
- 2:08Speaker 2: sales in vaccines. Flu shots and its RSV medicine came
- 2:14Speaker 2: under a bit of pressure in the U.S. However, it
- 2:16Speaker 2: is also highlighting its reliance on the drug, and that
- 2:19Speaker 2: is due to lose its patent protection early on in
- 2:22Speaker 2: the next decade. So, investors are currently waiting for some
- 2:26Speaker 2: sort of big acquisition to help plug that gap in time. So,
- 2:30Speaker 2: that is a key theme for the stock to watch
- 2:32Speaker 2: going forward.
- 2:33Speaker 3: Okay, so that with the drug maker Sanofi. Let's lastly
- 2:38Speaker 3: pounce on the earnings from Puma.
- 2:41Speaker 1: Yes.
- 2:42Speaker 2: German sportswear brand is up over 6% today in a
- 2:44Speaker 2: two-month high. It's basically showing progress with its turnaround efforts.
- 2:48Speaker 2: Third quarter sales were in line of expectations. There's been
- 2:51Speaker 2: no change to guidance, but that's all being welcomed. 2026
- 2:54Speaker 2: is being treated as a bit of a transitional year
- 2:57Speaker 2: for Puma. It's grappling with an array of headwinds, including
- 3:00Speaker 2: excess inventories and trying to bring new products to market.
- 3:04Speaker 2: And that's in the hope of setting the firm up
- 3:06Speaker 2: for a better 2027, where it can step up competition
- 3:09Speaker 2: against those bigger rivals like Adidas and Nike. The company
- 3:13Speaker 2: said it's still seeing weakness in some areas, but there
- 3:16Speaker 2: is momentum in, say, running shoes and training apparel. And
- 3:20Speaker 2: although it's still expecting losses this year, today's update is
- 3:23Speaker 2: clearly providing confidence that the firm is on the right path.
- 3:27Speaker 1: The Stock Movers Report from Bloomberg Radio. Check back with
- 3:31Speaker 1: us throughout the day for the latest roundup of companies
- 3:34Speaker 1: making news on Wall Street. And for the latest market-moving headlines,
- 3:38Speaker 1: listen to Bloomberg Radio Live. Catch us on YouTube, Bloomberg.com,
- 3:43Speaker 1: and on Apple CarPlay and Android Auto with the Bloomberg
- 3:46Speaker 1: Business app.